A. M. Gianni

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

G.B. Ryan, Giovanni Martinelli, Marion Kuper‐Hommel et al. · Annals of Oncology · 2007 · 251 citations · Full text

Medicine, Oncology, Pathology +8

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

Pier Luigi Zinzani, Simonetta Viviani, A. Anastasia et al. · Haematologica · 2013 · 72 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Dose intensive therapy in breast cancer.

Karen H. Antman, Robert Corringham, Elisabeth G.E. de Vries et al. · PubMed · 1992 · 72 citations

Medicine, Oncology, Breast Oncology +11

Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer

Paolo Corradini, Claudia Voena, Monica Astolfi et al. · Annals of Oncology · 2001 · 68 citations

Medicine, Oncology, Pathology +17

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease — A 6-year update

A. M. Gianni, Salvatore Siena, Marco Bregni et al. · Annals of Oncology · 1993 · 64 citations · Full text

Medicine, Oncology, Radiation Oncology +15